Abstract
Inhibition of tumor metastasis is one of the most important purposes in colorectal cancer (CRC) treatment. This study aimed to explore the effects of liquiritigenin, a flavonoid extracted from the roots of Glycyrrhiza uralensis Fisch, on HCT116 cell proliferation, invasion, and epithelial-to-mesenchymal transition (EMT). We found that liquiritigenin significantly inhibited HCT116 cell proliferation, invasion, and the EMT process, but had no influence on cell apoptosis. Moreover, liquiritigenin remarkably reduced the expression of runt-related transcription factor 2 (Runx2) in HCT116 cells. Overexpression of Runx2 obviously reversed the liquiritigenin-induced invasion and EMT inhibition. Furthermore, liquiritigenin inactivated the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway in HCT116 cells. Upregulation of Runx2 reversed the liquiritigenin-induced PI3K/AKT pathway inactivation. In conclusion, our research verified that liquiritigenin exerted significant inhibitory effects on CRC invasion and EMT process by downregulating the expression of Runx2 and inactivating the PI3K/AKT signaling pathway. Liquiritigenin could be an effective therapeutic and preventative medicine for CRC treatment.
References
Jun 13, 1992·Lancet·I R Hart, A Saini
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 2, 2006·Chemico-biological Interactions·Young Woo KimSang Geon Kim
May 4, 2006·The Journal of Biological Chemistry·Philip Y WaiPaul C Kuo
Mar 1, 2007·Planta medica·Yong-Wook ShinDong-Hyun Kim
Mar 12, 2008·British Journal of Pharmacology·Y W KimS C Kim
Aug 2, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·René KupferUwe Christians
Dec 9, 2008·The Journal of Surgical Research·Philippe ZerbibBrigitte Jude
Dec 3, 2009·Phytotherapy Research : PTR·Ming ZhouYunqing Cai
Dec 31, 2010·Cell Cycle·Theodore S NowickiJan Geliebter
Mar 8, 2012·International Journal of Cancer. Journal International Du Cancer·Tomohiko SaseHironobu Sasano
Apr 24, 2012·Nutrition and Cancer·Yu WangYunqing Cai
May 30, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Dong-Feng NiuRyohei Katoh
Jun 14, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuxin LiuYunqing Cai
Jun 28, 2012·Gut·Keun HurAjay Goel
Sep 10, 2013·Journal of Experimental & Clinical Cancer Research : CR·Masanobu TsubakiShozo Nishida
Sep 10, 2013·Neurotoxicology·Eun-Ju YangKyung-Sik Song
Jul 6, 2014·PloS One·Yaqin WangQuanhong Liu
May 13, 2015·Oncotarget·Tao FangJinjun Li
May 16, 2015·Nutrition and Cancer·Hui ShiYunqing Cai
Jul 15, 2015·Phytotherapy Research : PTR·Kaho UchinoTakayuki Tsukuba
Jul 19, 2015·BMC Genomics·Bing TianAllan R Brasier
Jul 25, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ji-Yeon YuSeikwan Oh
Feb 20, 2016·PloS One·Haruo ShimizuMasao Hosokawa
Jun 9, 2016·Oncotarget·Lai XuWei Ge
Jan 16, 2017·Human Immunology·Pâmela PortelaMariana Jobim
Apr 6, 2017·Journal of Cellular Biochemistry·Rui JiangHan Wu
Citations
Jun 12, 2020·Cancers·Alena LiskovaPeter Kubatka
Sep 18, 2020·Experimental Biology and Medicine·Fang LiangLu Yin
May 23, 2020·Biomolecules·Hyun-Su LeeGil-Saeng Jeong
Jan 9, 2019·Frontiers in Pharmacology·Aeyung Kim, Jin Yeul Ma
May 10, 2021·International Journal of Biological Macromolecules·Xueling YuanSuliman Khan
May 18, 2021·Frontiers in Pharmacology·Jia ChenShuangcheng Ma
Jun 5, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shi WuJinhao Zeng
Jun 22, 2021·Frontiers in Pharmacology·Mianmian LiaoNeng Wang
Aug 8, 2021·Cancers·Katyana Amilca-SebaJérôme A Denis
Sep 8, 2021·Bioengineered·Yingchen JiJin Fang
Nov 28, 2020·Journal of Ethnopharmacology·Zhixin ZhangYing Liu